A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A minimally invasive procedure for fixing diseased aortic valves is just as safe and durable as traditional surgery after five years, a new study reports.
Several faculty members from the VP&S Department of Physiology & Cellular Biophysics gave presentations at the latest in the medical school’s Afternoon of Science series.
A new mouse model may be critical for understanding the most aggressive types of pancreatic cancer and finding ways to prevent its growth and recurrence.
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.